Search research articles
Contact Us
Filters
Showing results (311-320 of 342) with videos related to
Page
of 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2019
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
Robert F Cornell, Bonnie Ky, Brendan M Weiss, et al.
The Journal of Clinical Investigation
|
March 22, 2019
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma
Adam D Cohen, Alfred L Garfall, Edward A Stadtmauer, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target
Zhiwei Ang, Annette Castro, Luca Paruzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Dynamics Tracking
Hui Chen, Zhao Li, Sheng Feng, et al.
Blood
|
October 30, 2010
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
American Journal of Hematology
|
November 24, 2021
A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma
Robert Frank Cornell, Rachid Baz, Joshua R Richter, et al.
Blood
|
September 14, 2021
A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma
Muzaffar H Qazilbash, Neeraj Y Saini, Soung-Chul Cha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2019
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
L Khoja, E G Atenafu, S Suciu, et al.
Radiation and Environmental Biophysics
|
June 15, 2017
Erratum to: Risk of cancer incidence before the age of 15 years after exposure to ionising radiation from computed tomography: results from a German cohort study
L Krille, S Dreger, R Schindel, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 342) with videos related to
Sort By:
Page
of 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2019
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
Robert F Cornell, Bonnie Ky, Brendan M Weiss, et al.
The Journal of Clinical Investigation
|
March 22, 2019
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma
Adam D Cohen, Alfred L Garfall, Edward A Stadtmauer, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target
Zhiwei Ang, Annette Castro, Luca Paruzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Dynamics Tracking
Hui Chen, Zhao Li, Sheng Feng, et al.
Blood
|
October 30, 2010
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
American Journal of Hematology
|
November 24, 2021
A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma
Robert Frank Cornell, Rachid Baz, Joshua R Richter, et al.
Blood
|
September 14, 2021
A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma
Muzaffar H Qazilbash, Neeraj Y Saini, Soung-Chul Cha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2019
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
L Khoja, E G Atenafu, S Suciu, et al.
Radiation and Environmental Biophysics
|
June 15, 2017
Erratum to: Risk of cancer incidence before the age of 15 years after exposure to ionising radiation from computed tomography: results from a German cohort study
L Krille, S Dreger, R Schindel, et al.
Page
of 35